RNAC
Cartesian Therapeutics Inc.
$8.52
+$0.07(+0.83%)
48
Overall
40
Value
54
Tech
52
Quality
Market Cap
$205.43M
Volume
173.66K
52W Range
$5.98 - $20.30
Target Price
$35.29
Latest News for RNAC
Analysts Offer Insights on Healthcare Companies: Cartesian Therapeutics (RNAC) and Galmed Pharmaceuticals (GLMD)
Brian Anderson•25 days ago•Nov 18, 2025
Analysts fell to the sidelines weighing in on Cartesian Therapeutics (RNAC – Research Report) and Galmed Pharmaceuticals (GLMD – Research Report) w......
Wedbush Remains a Buy on Cartesian Therapeutics (RNAC)
TipRanks Auto-Generated Intelligence Newsdesk•a month ago•Nov 14, 2025
In a report released today, Martin Fan from Wedbush maintained a Buy rating on Cartesian Therapeutics, with a price target of $38.00. Fan covers th......
Cantor Fitzgerald Sticks to Its Hold Rating for Cartesian Therapeutics (RNAC)
TipRanks Auto-Generated Intelligence Newsdesk•a month ago•Nov 14, 2025
In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Hold rating on Cartesian Therapeutics, with a price target of $1......
News data is sourced from MarketXLS API and updated regularly.
Showing 3 of 3 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RNAC | $8.52 | +0.8% | 173.66K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cartesian Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW